Current Status of PRP Manufacturing Requirements and European Regulatory Frameworks: Practical Tools for the Appropriate Implementation of PRP Therapies in Musculoskeletal Regenerative Medicine
February 2023
in “
Bioengineering
”
TLDR Standardizing PRP therapy practices and regulations in Europe is crucial for safe and effective treatment.
The document discusses the challenges and requirements for implementing platelet-rich plasma (PRP) therapies in musculoskeletal regenerative medicine within Europe, focusing on the need for standardization and adherence to good manufacturing practices (GMP). It highlights the disparity in legislation across European countries and the importance of defining workflows and technical specifications for PRP preparation to ensure high therapeutic quality. The work provides simplified legislative information and recommendations for medical practitioners in Western Europe, aiming to facilitate the safe and effective use of PRP treatments by ensuring informed regulatory and process-based decisions.